Microbix Biosystems Inc. to Shine at Bloom Burton Conference
Microbix Biosystems Inc. Attending the Bloom Burton Conference
Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF), known for its innovative contributions to the life sciences sector, is excited to announce its participation at the Bloom Burton & Co. Healthcare Investor Conference. This significant event will take place at the Metro Toronto Convention Centre.
Networking Opportunities at the Conference
The Bloom Burton Conference serves as a prestigious platform for Microbix to engage with a diverse group of investors from Canada, the U.S., and around the globe. Cameron Groome, the CEO and President of Microbix, will deliver a group presentation on the second day of the conference, providing insight into the company’s latest advancements and business strategies. The time for this presentation is scheduled for 2:30 p.m. Eastern Time on the aforementioned day.
Engagement Between Management and Investors
In addition to the general presentation, Microbix's senior management team will be actively participating in one-on-one meetings with potential investors. This approach underscores Microbix’s commitment to fostering strong relationships within the investment community and sharing its vision with stakeholders who are equally passionate about the future of healthcare and life sciences.
An Overview of Microbix's Offerings
Microbix Biosystems focuses on creating proprietary biological products that contribute significantly to human health. With a dedicated team of over 120 employees, the company is steadily growing, currently targeting revenues of C$2 million or more each month. Their product line primarily includes critical ingredients and devices for the global diagnostics industry, such as antigens for immunoassays and Quality Assessment Products (QAPs™), which play an essential role in laboratory proficiency testing.
Global Reach of Microbix Products
Microbix products have an impressive reach, being available in over 30 countries through a robust network of international distributors. Their QAPs support clinical labs and diagnostic companies in maintaining high quality standards, helping to ensure that clinical diagnostic workflows are precise and reliable. Microbix maintains strict quality controls enforced by its ISO 9001 & 13485 accreditations and U.S. FDA registrations.
Innovations in Thrombolytic Treatment
Furthermore, Microbix is leveraging its biological expertise to expand its product range, including Kinlytic® urokinase, a crucial thrombolytic treatment for blood clots. Additionally, the company is innovating in molecular diagnostic support with products like their DxTM™ for patient-sample collection, showcasing its adaptability and responsiveness to the evolving healthcare landscape.
About Bloom Burton & Co.
Bloom Burton & Co. plays a vital role in the healthcare sector, assisting both investors and companies to accelerate returns. Their seasoned team conducts thorough due diligence and applies creative strategies to facilitate optimal monetization events for their clients. Their services encompass capital raising, merger and acquisition advisory, equity research, and strategic corporate guidance, proving to be integral in the healthcare investment community.
Continuing to Improve Healthcare Solutions
As the healthcare landscape continues to evolve, Microbix is poised to leverage opportunities for innovation and growth. Their presence at impactful conferences like Bloom Burton highlights their commitment to advancing healthcare solutions and engaging with investors committed to the same goals.
Contact Information for Inquiries
For those looking to follow up or inquire further, Microbix extends an invitation. Interested parties can reach out to Cameron Groome, CEO at (905) 361-8910, or Jim Currie, CFO at the same number. For investor relations inquiries, Deborah Honig can be contacted at (647) 203-8793 or via email.
Frequently Asked Questions
What is the Bloom Burton Conference?
The Bloom Burton Conference is a significant healthcare investor event, focused on opportunities in life sciences and healthcare investments.
When will Microbix present during the conference?
Microbix will present on Tuesday at 2:30 p.m. Eastern Time.
What products does Microbix Biosystems offer?
Microbix offers proprietary biological products including antigens for immunoassays and QAPs™ for laboratory testing.
How does Microbix ensure product quality?
Microbix is ISO certified and registered with FDA, allowing them to maintain high-quality standards across their product lines.
Who can I contact for more information about Microbix?
For inquiries, contact CEO Cameron Groome at (905) 361-8910 or reach out to Investor Relations via email.
About The Author
Contact Thomas Cooper privately here. Or send an email with ATTN: Thomas Cooper as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.